Wird geladen...
Impact of the occurrence of new lesions on the survival of patients who undergo chemotherapy for metastatic colorectal cancer
In clinical practice, the efficacy of chemotherapy for metastatic colorectal cancer (mCRC) is typically evaluated according to the Response Evaluation Criteria in Solid Tumours (RECIST) criteria, and an appropriate treatment plan is determined. In the case of progressive disease (PD), the components...
Gespeichert in:
| Veröffentlicht in: | Mol Clin Oncol |
|---|---|
| Hauptverfasser: | , , , , , , , |
| Format: | Artigo |
| Sprache: | Inglês |
| Veröffentlicht: |
D.A. Spandidos
2019
|
| Schlagworte: | |
| Online Zugang: | https://ncbi.nlm.nih.gov/pmc/articles/PMC6327212/ https://ncbi.nlm.nih.gov/pubmed/30680209 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.3892/mco.2018.1778 |
| Tags: |
Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
|